CELL INTELLIGENCE · 肿瘤细胞治疗研究

UCMSC-Exo 用于急性髓系白血病化疗诱导的骨髓抑制：一项 I 期临床试验方案

UCMSC-Exo for chemotherapy-induced myelosuppression in acute myeloid leukemia: a phase I clinical trial protocol.

人脐带间充质干细胞来源外泌体增强 anti-miR-10b 对胶质母细胞瘤的治疗效果

Human umbilical cord mesenchymal stem cells derived exosomes enhance the therapeutic efficacy of anti-miR-10b in glioblastoma.

0.1% 过氧乙酸处理是卵巢脱细胞细胞外基质的最佳工艺

0.1% Peracetic Acid Treatment Is the Optimal Process for Ovarian Decellularized Extracellular Matrix.

Th17 驱动的 CD8(+) T 细胞在 hUC-MSC 与 CAR-T 细胞双重免疫治疗中的卓越抗肿瘤疗效

Th17-driven CD8(+) T cells in hUC-MSC and CAR T-cell dual immunotherapy for superior anti-tumor efficacy.

脐带间充质干细胞外泌体在乳腺癌中的应用：虚假希望还是真正解决方案？

Umbilical cord mesenchymal stem cell exosomes in breast cancer. False hope or a real solution?

间充质干细胞共递送趋化因子 CXCL9 和共刺激配体 TNFSF9 重编程三阴性乳腺癌的免疫微环境

Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative br

利用工程化间充质干细胞来源的细胞外囊泡开展创新性肿瘤治疗

Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments.

人脐带间充质干细胞来源外泌体通过 let-7i-5p/Faslg 轴减轻肝脏缺血再灌注损伤

Exosomes derived from human umbilical cord mesenchymal stem cells attenuate hepatic ischaemia-reperfusion injury via the let-7i-5p/Faslg axis.

我们的研究结果表明，hucMSC-exos 通过抑制细胞凋亡减轻 HIRI。

人脐带间充质干细胞来源外泌体通过 ROS-Fas 通路增强顺铂诱导的人 NPC-TW01 鼻咽癌细胞凋亡效应

Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Cisplatin-induced Apoptotic Effects via the ROS-Fas Pathway in Human NPC-TW0

hUC MSC-Exos 通过 ROS 依赖性激活 Fas 相关凋亡信号通路增强顺铂对 NPC-TW01 细胞的细胞毒性。这些结果表明，hUC MSC-Exos 可能作为一种有前景的佐剂，增强顺铂在 NPC 中的治疗效果。

IFN-γ 和/或 TNF-α 预处理的 hUC-MSC 分泌组的治疗潜力：阿尔茨海默病神经元细胞模型的体外研究

Therapeutic potential of hUC-MSC secretome preconditioned with IFN-γ and/or TNF-α: An in vitro study on Alzheimer's neuronal cell models.